Personalized medicine in oncology: the future is now
- PMID: 20431568
- DOI: 10.1038/nrd3181
Personalized medicine in oncology: the future is now
Abstract
Cancer chemotherapy is in evolution from non-specific cytotoxic drugs that damage both tumour and normal cells to more specific agents and immunotherapy approaches. Targeted agents are directed at unique molecular features of cancer cells, and immunotherapeutics modulate the tumour immune response; both approaches aim to produce greater effectiveness with less toxicity. The development and use of such agents in biomarker-defined populations enables a more personalized approach to cancer treatment than previously possible and has the potential to reduce the cost of cancer care.
Comment in
-
Gene and drug matrix for personalized cancer therapy.Nat Rev Drug Discov. 2010 Aug;9(8):660. doi: 10.1038/nrd3181-c1. Nat Rev Drug Discov. 2010. PMID: 20671766 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
